Design and results of the antiarrhythmics vs implantable defibrillators (AVID) registry

Circulation

Volumn 99, Issue 13, 1999, Pages 1692-1699

  Anderson, Jeffrey L ^a   Hallstrom, Alfred P ^a,b   Epstein, Andrew E ^a   Pinski, Sergio L ^a   Rosenberg, Yves ^a   Nora, Matthew O ^a   Chilson, Donald ^a   Cannom, David S ^a   Moore, Rich ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b AVID CTC   (United States)

Author keywords

Antiarrhythmia agents; Death, sudden; Fibrillation; Registries; Tachycardia

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; NITRATE; SOTALOL; WARFARIN;

ADULT; AGED; ARTICLE; DEFIBRILLATOR; DEMOGRAPHY; FEMALE; HEART ARREST; HEART ARRHYTHMIA; HEART VENTRICLE ARRHYTHMIA; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RISK ASSESSMENT; SYNCOPE;

EID: 0033528757     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.99.13.1692     Document Type: Article

References (26)

1. Nichol G, Hallstrom AP, Ornato JP, Riegel B, Stiell IG, Valenzuela T, Wells GA, White RD, Weisfeldt ML. Potential cost-effectiveness of public access defibrillation in the United States. Circulation. 1998; 97:1315-1320.
2. Cobb LA, Baum RS, Alvarez H III, Schaffer WA. Resuscitation from out-of-hospital ventricular fibrillation: 4 years follow-up. Circulation. 1975;52:(suppl III):III-223-III-235.
3. Goldstein S, Landis JR, Leighton R, Ritter G, Vasu CM, Wolfe RA, Acheson A, Vanderburg-Medendorp S. Predictive survival models for resuscitated victims of out-of-hospital arrest with coronary heart disease. Circulation. 1985;71:873-880.
4. The Cardiac Arrhythmia Suppression Trial (CAST) Investigators. Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med. 1989;321:406-412.
5. Waldo AL, Camm AJ, deRuyter H, Friedman PL, MacNeil DJ, Pauls JF, Pitt B, Pratt CM, Schwartz PJ, Veltri EP. Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. Lancet. 1996;348:7-12; 416.
6. Mason JW. A comparison of seven antiarrhythmic drugs in patients with ventricular tachyarrhythmias. N Engl J Med. 1993;329:452-458.
7. The CASCADE Investigators. Randomized antiarrhythmic drug therapy in survivors of cardiac arrest (the CASCADE Study). Am J Cardiol. 1993;72:280-287.
8. Julian DG, Jackson FL, Prescott RJ, Szekely P. Controlled trial of sotalol for one year after myocardial infarction. Lancet. 1982;i:1142-1150.
9. Julian DG, Camm AJ, Frangin G, Janse MJ, Munoz A, Schwartz PJ, Simon P. Randomized trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. Lancet. 1997;349:667-674; 1180.
10. Cairns JA, Connolly SJ, Roberts R, Gent M. Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarizations: CAMIAT. Lancet. 1997;349:675-682.
11. Lehmann MH, Steinman RT, Schuger CD, Jackson K. The automatic implantable cardioverter defibrillator as antiarrhythmic treatment modality of choice for survivors of cardiac arrest unrelated to acute myocardial infarction. Am J Cardiol. 1988;62:803-805.
12. Winkle RA, Mead RH, Ruder MA, Gaudiani VA, Smith NA, Buch WS, Schmidt P, Shipman T. Long-term outcome with the automatic implantable cardioverter-defibrillator. J Am Coll Cardiol. 1989;13:1353-1361.
13. Maloney J, Masterson M, Khoury D, Trohman R, Wilkoff B, Simmons T, Morant V, Castle L. Clinical performance of the implantable cardioverter defibrillator: electrocardiographic documentation of 191 spontaneous discharges. Pacing Clin Electrophysiol. 1991;14: 230-235.
14. Zipes DP, Roberts D. Results of the international study of the implantable pacemaker cardioverter-defibrillator: a comparison of epicardial and endocardial lead systems. Circulation. 1995;92:59-65.
15. Siebels J, Kuck KH. Implantable cardioverter defibrillator compared with antiarrhythmic drug treatment in cardiac arrest survivors (the Cardiac Arrest Study Hamburg). Am Heart J. 1994;127:1139-1144.
16. Wever EF, Hauer RN, Schrijvers G, van Capelle FJ, Tijssen JG, Crijns HJ, Algra A, Ramanna H, Bakker PF, Robles de Medina EO. Tiered strategy in postinfarct sudden death survivors: a randomized study. Circulation. 1996;93:489-496.
17. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, Levine JH, Saksena S, Waldo AL, Wilber D, Brown MW, Heo M. Improved survival with an implanted defibrillator in patients with CAD at high risk for ventricular arrhythmia. N Engl J Med. 1996; 335:1933-1940.
18. The AVID Investigators. Antiarrhythmics Versus Implantable Defibrillators (AVID): rationale, design, and methods. Am J Cardiol. 1995;75:470-475.
19. Connolly SJ, Gent M, Roberts RS, Dorian P, Green MS, Klein GJ, Mitchell LB, Sheldon RS, Roy D. Canadian Implantable Defibrillator Study (CIDS): study design and organization. Am J Cardiol. 1993; 72:103F-108F.
20. Bigger JT Jr, for the CABG Patch Investigators. Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary artery bypass graft surgery. N Engl J Med. 1997;337:1468-1475.
21. The Antiarrhythmics Versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med. 1997;337:1576-1583.
22. Kim SG, Hallstrom A, Love JC, Rosenberg Y, Powell J, Roth J, Brodsky M, Moore R, Wilkoff B, for the AVID Investigators. Comparison of clinical characteristics and frequency of implantable defibrillator use between randomized patients in the Antiarrhythmics Versus Implantable Defibrillators (AVID) trial and nonrandomized registry patients. Am J Cardiol. 1997;80:454-457.
23. Boyle CA, Decouflé T. National sources of vital status information: extent of coverage and possible selectivity in reporting. Am J Epidemiol. 1990;131:160-168.
24. Kaplan EL, Meier P. Nonparametric estimator from incomplete observations. J Am Stat Assoc. 1958;53:457-481.
25. Peto R, Peto J. Asymptotically efficient rank invariant test procedures (with discussion). J R Stat Soc A. 1972;135:185-206.
26. Willems AR, Tijssen JG, vanCapelle FJ, Kingma JH, Hauer RN, Vermeulen FE, Brugada P, van Hoogenhuyze DC, Janse MJ, the Dutch Ventricular Tachycardia Study Group of the Interuniversity Cardiology Institute of the Netherlands. Determinants of prognosis in symptomatic ventricular tachycardia or ventricular fibrillation late after myocardial infarction. J Am Coll Cardiol. 1990;16: 521-530.